Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Microsure Bv |
| Country | Netherlands |
| Start Date | Jan 01, 2022 |
| End Date | Apr 30, 2024 |
| Duration | 850 days |
| Number of Grantees | 1 |
| Roles | Coordinator |
| Data Source | European Commission |
| Grant ID | 190126849 |
The revolution in microsurgery is here.
Microsure, a highly innovative Dutch medical device company is introducing MUSA, the worlds first clinically available CE-certified microsurgical robot.
We will maximize microsurgical performance by offering superhuman precision and comfort through robotic assistance in pursuit of excellence for both patients and health providers. The MUSA robot is highly efficient thereby reducing costs and improving access to microsurgical procedures.
With the great unmet need in microsurgery, we are convinced that the timing for market introduction of MUSA is right and the field is ready to accept and implement MUSA for better patient outcomes.
In this project, we will tackle the remaining bottlenecks for succesful outroll of the product including upscaling and optimizing manufacturability, to allow for rapid market uptake of MUSA after the project. MicroSure will introduce MUSA in all parts of Europe before 2029, reaching major societal and economic impact.
Microsure Bv
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant